-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Chemical Machinery Equipment Network Star Enterprise ] According to industry statistics, as of July 15, 2021, of the total 220 companies in the machinery and special equipment industry, 52 companies have released 2021 semi-annual performance forecasts
.
Among them, 49 companies are pre-happy, accounting for 94.
23%.
The average net profit of industry forecasts attributable to the parent is 233 million yuan, and the average growth rate of net profit attributable to the parent is 699.
47%
.
So while the entire machinery and equipment industry is generally improving, what about the performance of pharmaceutical equipment companies in the first half of the year?
Chemical machinery equipment network star enterprise chemical machinery equipment pharmaceutical equipment.
Among them, 49 companies are pre-happy, accounting for 94.
23%.
The average net profit of industry forecasts attributable to the parent is 233 million yuan, and the average growth rate of net profit attributable to the parent is 699.
47%
.
So while the entire machinery and equipment industry is generally improving, what about the performance of pharmaceutical equipment companies in the first half of the year?
From the current point of view, the general increase in the market demand for pharmaceutical equipment in the first half of this year has driven the sales performance of many companies
.
Specifically, on July 14, Canaan Technology released a 2021 semi-annual performance forecast.
The company expects the net profit attributable to shareholders of listed companies in the first half of 2021 to be 36.
6704 million yuan to 45.
132 million yuan, an increase of 30% to 60% year-on-year
.
On July 6, Tofflon disclosed the 2021 semi-annual results forecast, and it is expected to achieve a net profit attributable to shareholders of the listed company of about 310 million yuan-about 344 million yuan, a year-on-year increase of 80%-100%
.
On July 3, Xinlai Yingcai released its first-half performance forecast.
It is estimated that your net profit attributable to shareholders of listed companies in the first half of 2021 will be 58.
0 million to 68.
0 million, a year-on-year change of 71.
82% to 101.
44%
.
.
Specifically, on July 14, Canaan Technology released a 2021 semi-annual performance forecast.
The company expects the net profit attributable to shareholders of listed companies in the first half of 2021 to be 36.
6704 million yuan to 45.
132 million yuan, an increase of 30% to 60% year-on-year
.
On July 6, Tofflon disclosed the 2021 semi-annual results forecast, and it is expected to achieve a net profit attributable to shareholders of the listed company of about 310 million yuan-about 344 million yuan, a year-on-year increase of 80%-100%
.
On July 3, Xinlai Yingcai released its first-half performance forecast.
It is estimated that your net profit attributable to shareholders of listed companies in the first half of 2021 will be 58.
0 million to 68.
0 million, a year-on-year change of 71.
82% to 101.
44%
.
Judging from the positive performance of many companies mentioned above, the industry predicts that the overall performance of pharmaceutical equipment industry companies in the first half of 2021 will also perform better.
Most pharmaceutical equipment companies will achieve faster performance by actively promoting their own development strategies.
Development
.
In the future, as the consumption level upgrades and people's awareness of health care increases, as the pharmaceutical industry develops further, the pharmaceutical equipment industry will also usher in more development opportunities
.
Most pharmaceutical equipment companies will achieve faster performance by actively promoting their own development strategies.
Development
.
In the future, as the consumption level upgrades and people's awareness of health care increases, as the pharmaceutical industry develops further, the pharmaceutical equipment industry will also usher in more development opportunities
.
However, it is worth noting that compared with small and medium-sized pharmaceutical equipment companies with small R&D investment and weak technology, the industry believes that the competitive advantages of large companies may be more apparent in the future
.
In addition, as industry competition intensifies and the public pays more attention to drug safety, pharmaceutical companies will also put forward higher requirements for the safety, production efficiency, and stability of pharmaceutical equipment
.
In this regard, the industry proposes that pharmaceutical equipment companies should comply with market demand, accelerate technological innovation, expand cooperation with foreign countries, improve the manufacturing level and production capacity of China's pharmaceutical equipment at a higher level and on a larger scale, and move toward integration and intelligence.
, The direction of internationalization accelerates development
.
.
In addition, as industry competition intensifies and the public pays more attention to drug safety, pharmaceutical companies will also put forward higher requirements for the safety, production efficiency, and stability of pharmaceutical equipment
.
In this regard, the industry proposes that pharmaceutical equipment companies should comply with market demand, accelerate technological innovation, expand cooperation with foreign countries, improve the manufacturing level and production capacity of China's pharmaceutical equipment at a higher level and on a larger scale, and move toward integration and intelligence.
, The direction of internationalization accelerates development
.
It is understood that, in terms of integration, China's pharmaceutical equipment has already entered an era of integrated process operation technology from the simple monomer era
.
For example, a company has always paid great attention to product development, and is constantly developing and producing single products in the direction of integrated products
.
At present, compared with the original domestic similar products, the spiral wound tube heat exchanger developed by it has optimized the product volume and increased the heat exchange efficiency.
The optimized product has higher heat exchange efficiency and improved solvent recovery rate.
In addition, the integrated temperature control unit enables customers to make temperature control more accurate during use, and the product qualification rate is higher
.
Heat Exchanger.
For example, a company has always paid great attention to product development, and is constantly developing and producing single products in the direction of integrated products
.
At present, compared with the original domestic similar products, the spiral wound tube heat exchanger developed by it has optimized the product volume and increased the heat exchange efficiency.
The optimized product has higher heat exchange efficiency and improved solvent recovery rate.
In addition, the integrated temperature control unit enables customers to make temperature control more accurate during use, and the product qualification rate is higher
.
In terms of intelligence, automation
.
Intelligent equipment has long become the main direction of innovation and research and development of pharmaceutical equipment companies
.
Many companies, including Chutian Technology, Canaan Technology, and Tofflon, have already begun to use Internet platforms and technologies to carry out intelligent product layout and innovative research and development
.
At present, its intelligent achievements are also constantly appearing
.
.
Intelligent equipment has long become the main direction of innovation and research and development of pharmaceutical equipment companies
.
Many companies, including Chutian Technology, Canaan Technology, and Tofflon, have already begun to use Internet platforms and technologies to carry out intelligent product layout and innovative research and development
.
At present, its intelligent achievements are also constantly appearing
.
In terms of international layout, it is also bringing growth momentum to the domestic pharmaceutical equipment industry
.
From the general background, China's pharmaceutical equipment industry has developed rapidly in recent years.
From the extensive production model in the past, it is developing steadily towards high precision and high quality.
At the same time, the industry is constantly transforming and upgrading
.
Affected by this, more and more pharmaceutical machinery companies have also started an international strategic layout, and while meeting the needs of the domestic market, they are moving to the international stage
.
In this way, the former Tofflon said on the interactive platform that the company has deployed "international" business since 2004, and by the end of 2020, the company's international operating income accounted for about 20%
.
.
From the general background, China's pharmaceutical equipment industry has developed rapidly in recent years.
From the extensive production model in the past, it is developing steadily towards high precision and high quality.
At the same time, the industry is constantly transforming and upgrading
.
Affected by this, more and more pharmaceutical machinery companies have also started an international strategic layout, and while meeting the needs of the domestic market, they are moving to the international stage
.
In this way, the former Tofflon said on the interactive platform that the company has deployed "international" business since 2004, and by the end of 2020, the company's international operating income accounted for about 20%
.
Looking forward to the future, with the continuous implementation of policies such as the normalization of centralized procurement, consistency evaluation, and new medical insurance negotiations, the new needs and new requirements of pharmaceutical companies in controlling costs and increasing production capacity will become more apparent
.
Affected by this, the domestic pharmaceutical equipment industry is also expected to usher in rapid development
.
But for pharmaceutical equipment companies, opportunities are often accompanied by challenges
.
In the context of the upgrading of the pharmaceutical industry, pharmaceutical equipment companies also need to accelerate the transformation to high-precision technology and high-end, and vigorously develop toward the trend of integration, intelligence, and internationalization
.
.
Affected by this, the domestic pharmaceutical equipment industry is also expected to usher in rapid development
.
But for pharmaceutical equipment companies, opportunities are often accompanied by challenges
.
In the context of the upgrading of the pharmaceutical industry, pharmaceutical equipment companies also need to accelerate the transformation to high-precision technology and high-end, and vigorously develop toward the trend of integration, intelligence, and internationalization
.
Original title: The performance of pharmaceutical machinery companies continues to improve, and it will accelerate development in three major directions
